Table 4.
Example of reporting baseline demographic and clinical characteristics.* (Adapted from table 1 of Yusuf et al209)
| Telmisartan (N=2954) | Placebo (N=2972) | |
|---|---|---|
| Age (years) | 66.9 (7.3) | 66.9 (7.4) |
| Sex (female) | 1280 (43.3%) | 1267 (42.6%) |
| Smoking status: | ||
| Current | 293 (9.9%) | 289 (9.7%) |
| Past | 1273 (43.1%) | 1283 (43.2%) |
| Ethnic origin: | ||
| Asian | 637 (21.6%) | 624 (21.0%) |
| Arab | 37 (1.3%) | 40 (1.3%) |
| African | 51 (1.7%) | 55 (1.9%) |
| European | 1801 (61.0%) | 1820 (61.2%) |
| Native or Aboriginal | 390 (13.2%) | 393 (13.2%) |
| Other | 38 (1.3%) | 40 (1.3%) |
| Blood pressure (mm Hg) | 140.7 (16.8/81.8) (10.1) | 141.3 (16.4/82.0) (10.2) |
| Heart rate (beats per min) | 68.8 (11.5) | 68.8 (12.1) |
| Cholesterol (mmol/l): | ||
| Total | 5.09 (1.18) | 5.08 (1.15) |
| LDL | 3.02 (1.01) | 3.03 (1.02) |
| HDL | 1.27 (0.37) | 1.28 (0.41) |
| Coronary artery disease | 2211 (74.8%) | 2207 (74.3%) |
| Myocardial infarction | 1381 (46.8%) | 1360 (45.8%) |
| Angina pectoris | 1412 (47.8%) | 1412 (47.5%) |
| Peripheral artery disease | 349 (11.8%) | 323 (10.9%) |
| Hypertension | 2259 (76.5%) | 2269 (76.3%) |
| Diabetes | 1059 (35.8%) | 1059 (35.6%) |
*Data are means (SD) or numbers (%).